Log in to save to my catalogue

The Th17 Pathway in Cystic Fibrosis Lung Disease

The Th17 Pathway in Cystic Fibrosis Lung Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3381840

The Th17 Pathway in Cystic Fibrosis Lung Disease

About this item

Full title

The Th17 Pathway in Cystic Fibrosis Lung Disease

Publisher

New York, NY: American Thoracic Society

Journal title

American journal of respiratory and critical care medicine, 2011-07, Vol.184 (2), p.252-258

Language

English

Formats

Publication information

Publisher

New York, NY: American Thoracic Society

More information

Scope and Contents

Contents

Cystic fibrosis (CF) is characterized by bronchoalveolar neutrophilia and submucosal lymphocytosis. We hypothesized that Th17 lymphocytes are part of this submucosal infiltrate.
Quantification and phenotyping of the lymphocytic infiltrate in the bronchial submucosa of patients with CF (n = 53, of which 20 were newly diagnosed), non-CF bronchiect...

Alternative Titles

Full title

The Th17 Pathway in Cystic Fibrosis Lung Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3381840

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3381840

Other Identifiers

ISSN

1073-449X

E-ISSN

1535-4970

DOI

10.1164/rccm.201102-0236OC

How to access this item